The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
851
August 23, 1991
View Complete Issue         Table of Contents 2019 
Alglucerase For Gaucher's Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Alglucerase For Gaucher's Disease
August 23, 1991 (Issue: 851)
(Ceredase - Genzyme) a modified form of the glycoprotein enzyme glucocerebrosidase prepared from human placenta, was recently approved by the US Food and Drug Administration as an 'orphan drug' for treatment of patients with the non-neurologic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Alglucerase For Gaucher's Disease
Article code: 851c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.